News

SAGA lands agreement with Region Örebro University Hospital to deploy ultrasensitive liquid biopsy testing in lung cancer

LUND, Sweden — /September 9, 2019/ — SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces it has entered a “lab-in-lab” customer agreement with the University Hospital Örebro (USÖ), Division of Laboratory Medicine, serving the…

Appointment of Director of Operations

LUND, Sweden — /September 2, 2019/ — SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces the appointment of a new Director of Operations, Johanna Asklin, PhD, an experienced professional project and portfolio manager in the…

SAGA raises 40 million SEK (€3.7 million) to advance ultrasensitive cancer liquid biopsies

LUND, Sweden and OSLO, Norway, June 11, 2019 — /B3C Newswire/ — SAGA Diagnostics AB, a precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tissues, today announces the raising of SEK 40 million in venture-backed financing (circa EUR…

SAGA appoints new Director of Finance

LUND, Sweden — /February 11, 2019/ — SAGA Diagnostics AB, a genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients using a simple blood sample, today announces the appointment of a new Director of Finance, Henrik Simonsen, a veteran strategic CFO with over 20 years…

Selected as Top 7 Start-Up Finalist in ‘Hello Tomorrow’ Global Heath Competition

LUND, Sweden — /January 10, 2019/ — SAGA Diagnostics announces today that we have been selected as a Worldwide Top 7 Finalist in the Global Health category, Hello Tomorrow Start-Up Competition!  Out of more than 4,500 companies from over 100 countries screened, we were selected by a prestigious industry panel…

Job opening: Medical Laboratory Scientist in molecular cancer diagnostics

Now hiring:  [*** POSITION FILLED ***] Medical Laboratory Scientist I/II in Lund, Sweden SAGA Diagnostics AB is seeking a team-oriented Medical Laboratory Scientist (laboratory technician) to join us in our mission to revolutionize cancer diagnostics through proprietary ultrasensitive technologies to measure circulating tumor DNA in minimally-invasive “liquid biopsies” such as a…

SAGA awarded €450,000 grant from Sweden’s SWElife Innovation Program

LUND, Sweden — /November 15, 2018/ — SAGA Diagnostics announced today it has been awarded a follow-on grant of SEK 4.7 million (~ €450,000) from the SWElife Accelerator Innovation Program to support the product development objectives of SAGA’s ultrasensitive technologies for monitoring cancer patients using simple blood samples and other…

Selected as a Top 500 Startup worldwide out of many thousands screened from over 100 countries

LUND, Sweden — /October 24, 2018/ — SAGA Diagnostics announces today that we have been selected as a Worldwide Top 500 Startup!  Out of many thousands of companies from over 100 countries screened, we were chosen by Hello Tomorrow and will participate in the Global Summit in Paris on March…

WntResearch selects SAGA’s ctDNA monitoring tool KROMA for phase 2 clinical trial

LUND, Sweden — /August 30, 2018/ — SAGA Diagnostics AB, a genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients using a simple blood sample, today announces it has entered a customer agreement with WntResearch AB, a Swedish biopharma company advancing new anti-cancer therapies targeting…

SAGA inks deal with Center for Molecular Diagnostics for lung cancer and leukemia tests

LUND, Sweden — /June 14, 2018/ — SAGA Diagnostics AB, a genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients using a simple blood sample, today announces it has entered a customer agreement with the Center for Molecular Diagnostics, Region Skåne, part of the Skåne…